Candriam SCA’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.99M | Buy |
524,161
+60,793
| +13% | +$579K | 0.03% | 350 |
|
|
2025
Q1 | $4.85M | Buy |
463,368
+61,973
| +15% | +$648K | 0.03% | 335 |
|
|
2024
Q4 | $9.46M | Buy |
401,395
+10,439
| +3% | +$246K | 0.05% | 268 |
|
|
2024
Q3 | $14M | Sell |
390,956
-142,317
| -27% | -$5.11M | 0.08% | 223 |
|
|
2024
Q2 | $18.8M | Sell |
533,273
-142,351
| -21% | -$5.02M | 0.11% | 181 |
|
|
2024
Q1 | $19.2M | Sell |
675,624
-88,000
| -12% | -$2.5M | 0.12% | 171 |
|
|
2023
Q4 | $10.2M | Buy |
763,624
+40,000
| +6% | +$532K | 0.07% | 248 |
|
|
2023
Q3 | $6.48M | Hold |
723,624
| – | – | 0.05% | 283 |
|
|
2023
Q2 | $8.14M | Buy |
723,624
+90,000
| +14% | +$1.01M | 0.06% | 268 |
|
|
2023
Q1 | $6.72M | Hold |
633,624
| – | – | 0.05% | 313 |
|
|
2022
Q4 | $7.34M | Buy |
633,624
+220,000
| +53% | +$2.55M | 0.05% | 323 |
|
|
2022
Q3 | $5.25M | Hold |
413,624
| – | – | 0.04% | 366 |
|
|
2022
Q2 | $2.84M | Buy |
413,624
+90,231
| +28% | +$620K | 0.02% | 427 |
|
|
2022
Q1 | $3.12M | Hold |
323,393
| – | – | 0.02% | 447 |
|
|
2021
Q4 | $3.85M | Hold |
323,393
| – | – | 0.02% | 407 |
|
|
2021
Q3 | $5.25M | Hold |
323,393
| – | – | 0.04% | 389 |
|
|
2021
Q2 | $6.8M | Buy |
+323,393
| New | +$6.8M | 0.05% | 347 |
|